The Pharmacogenomic Era in Asia: Potential Roles and Challenges for Asian PharmacistsYin-Fai Lee1, Ritchie Ching Chi Kwok2, Ian Chi Kei Wong2,3 and Vivian Wai Yan Lui4*
- *Corresponding Author:
- Lui VWY
School of Biomedical Sciences
Faculty of Medicine
The Chinese University of Hong Kong
Fax: (852) 2603-5123
E-mail: [email protected]
Received Date: January 16, 2017; Accepted Date: February 03, 2017; Published Date: February 13, 2017
Citation: Lee YF, Kwok RCC, Wong ICK, Lui VWY (2017) The Pharmacogenomic Era in Asia: Potential Roles and Challenges for Asian Pharmacists. J Pharmacogenomics Pharmacoproteomics 8:164. doi: 10.4172/2153-0645.1000164
Copyright: © 2017 Lee YF, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Personalized medicine through Pharmacogenomics: choosing the right drug, and the right dose, for the right patients based on patient’s genetic makeup-is gradually being realised in Western countries. Yet, the practice of pharmacogenomics in Asian countries lags behind that of the West, but the medical needs for pharmacogenomics are expected to surge as better patient care is demanded in Asia. As next-generation sequencing technology advances quickly, previous technical challenges for performing pharmacogenomic studies or practices in Asia have been mostly resolved. What is lacking in Asia is an effective model of community-wide pharmacogenomics. On the delivery front, pharmacists, the drug and dosing professionals, can potentially be the main healthcare providers for pharmacogenomic services in Asia. The first large “Genomics for Precision Drug Therapy in the Community Pharmacy” in Canada, which is close to its completion, has successfully identified community pharmacists as key contact professionals for smooth facilitation and implementation of pharmacogenomics for personalized medication. It is anticipated that Asian pharmacists, with appropriate training, can have the capacity to provide expert pharmacogenomic supports for both physicians and patients in Asia.